Skip to main content

Day: May 28, 2020

Visteon Adds Audio Call for Annual Meeting of Shareholders

VAN BUREN TOWNSHIP, Mich., May 28, 2020 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC) today announced it will host a listen-only call of its annual stockholders meeting in an effort to help safeguard the health and wellbeing of its shareholders, employees, directors and the community from the ongoing public health impact of the coronavirus (COVID-19) pandemic. The annual meeting will be held on Wednesday, June 3, at 11 a.m. EDT. Shareholders can still attend in person at Grace Lake Lodge, located on the campus of Visteon’s global headquarters and innovation center in Van Buren Township, Michigan. To participate in person or listen via the concurrent conference call, shareholders must register for meeting admission as described in the proxy statement filed April 23.The dial-in numbers to listen to the call are:U.S./Canada:...

Continue reading

Introducing Star Alliance International Corp.

Star Targets the Commencement of Mining OperationsWestlake Village, CA, May 28, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Star Alliance International Corp. (OTC Pink; STAL; “Star” or the “Company”) is pleased to introduce our Company to our shareholders and prospective investors.Richard Carey, CEO of Star Alliance International, stated, “We are excited to introduce our Company to you.  We are now planning to make the final payment due for the purchase of the mine and start the process of restarting mining operations. We are preparing the documentation necessary to obtain our permits and complete our plans to widen the road to the mine as well as refurbishing the on-site mining equipment. Our primary objectives are solid growth, profitability and improving Shareholder Value.”Corporate HistoryStar Alliance International...

Continue reading

Golar LNG Partners LP: Interim results for the period ended 31 March 2020

HighlightsExclusive of its interest in FLNG Hilli Episeyo, Golar LNG Partners LP (“Golar Partners” or “the Partnership”) generated operating income of $27.7 million for the first quarter of 2020.After accounting for $46.8 million of non-cash mark-to-market interest rate swap losses, the Partnership reported a net loss attributable to unit holders of $33.1 million for the first quarter.Generated distributable cash flow1 of $25.4 million for the first quarter resulting in a distribution coverage ratio1 of 17.79.Agreed to extend the LNGC Golar Grand charter for a further year.Subsequent EventsDeclared a distribution for the first quarter of $0.0202 per unit.Karl Fredrik Staubo appointed to succeed Graham Robjohns as CEO.Bondholders approved 18-month extensions to the May 2020 and May 2021 maturing high yield bonds.LNGC Golar Maria secured...

Continue reading

Silvercorp Launches a Drill Program for Gold Mineralization at the LMW, LME and TLP Mines, Ying Mining District, China

VANCOUVER, British Columbia, May 28, 2020 (GLOBE NEWSWIRE) — Silvercorp Metals Inc. (“Silvercorp” or the “Company”) is pleased to report that a drill program targeting gold (“Au”) mineralization is underway at the LMW, LME and TLP mines within the Ying Mining District, Henan Province, China.Silvercorp has previously reported limited gold assay results in news releases dated January 4, 2011, January 10, 2011, January 26, 2012, February 13, 2012, August 20, 2012, January 31, 2013 and February 19, 2014 for the LMW, LME and TLP mines, but as the focus was on mining silver-lead-zinc veins the characterization of gold mineralization was poorly understood. As such, many gold-bearing intercept results from drilling over the years have never been released as they do not fit into any known silver-lead-zinc veins that are mined...

Continue reading

Avance Gas Holding Ltd – Q1 2020 Presentation

Please find enclosed the presentation of Avance Gas Holding Ltd (OSE: AVANCE) for the first quarter 2020 results to be held on the webcast/conference call 28 May, 2020 at 14:00 CET.Attend by webcast:https://edge.media-server.com/mmc/p/2juk936dAttend by conference call:UK and International: +44 (0) 2071 928 000US: +1 631 510 7495Norway: +47 23 96 02 64Confirmation code: 9088721For further queries, please contact:Peder C. G. Simonsen, Interim CEO and CFOTel: +47 22 00 48 15ABOUT AVANCE GAS Avance Gas Holding Ltd operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world’s leading owners and operators of very large gas carriers (VLGCs), operating a fleet of 14 modern VLGC. For more information about Avance Gas, please visit: www.avancegas.com.This information is subject to the...

Continue reading

Datadog Announces Proposed Private Offering of $550 Million of Convertible Senior Notes

NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) — Datadog, Inc. (Nasdaq: DDOG), the monitoring and analytics platform for developers, IT operations teams and business users in the cloud age, today announced that it intends to offer, subject to market conditions and other factors, $550 million aggregate principal amount of convertible senior notes due 2025 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Datadog also intends to grant the initial purchasers of the notes an option to purchase up to an additional $82.5 million aggregate principal amount of notes.The notes will be senior unsecured obligations of Datadog and will accrue interest payable semiannually in arrears. The notes will be convertible...

Continue reading

Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZeneca, for manufacture of COVID-19 vaccine candidate

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZeneca, for manufacture of COVID-19 vaccine candidate         Oxford, UK – 28 May, 2020: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, announced today that it has signed a one year Clinical & Commercial Supply Agreement with AstraZeneca UK Ltd (“AstraZeneca”). The Agreement relates to the GMP manufacture of the adenovirus vector based COVID-19 vaccine candidate, AZD1222, which...

Continue reading

Little Green Pharma Continues Record Breaking Sales Growth

April 2020 – a record sales month with 1,850+ units sold, a 17% increase on March 2020 (previous record sales month)380 new patients prescribed LGP products in April (for a cumulative total of over 3,550 patients) and 28 new prescribersThe Office of Drug Control continues review of LGP’s application for an expanded Cultivation Permit and has granted an extension to LGP’s existing permit in the interimMONTRÉAL, May 28, 2020 (GLOBE NEWSWIRE) — Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELIXF) (FRA: 2LQA) (“ELIXXER” or (the “Company”) Pharmaceutical medical cannabis partner, Little Green Pharma (ASX:LGP) of Australia, has provided a sales update for the month of April 2020.LGP has achieved another record-breaking month in April 2020, with:Sales of 1,850+ units of LGP Classic product (a new monthly record), a 17% increase on March 2020...

Continue reading

Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer

– The NORA study meets all primary and secondary endpoints– Largest randomized clinical trial (RCT) in ovarian cancer ever conducted in China  – Individualized starting dose regimen shown to be effective with improved safety profile in Chinese patientsSHANGHAI and SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced positive topline results from the NORA study, the Phase 3 randomized, double-blind, placebo-controlled, study of ZEJULA (niraparib) as a maintenance therapy in Chinese patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer (collectively termed as ovarian cancer) who are in a complete or partial response to platinum-based chemotherapy.The NORA study randomized...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.